BioXcel Therapeutics Inc. (BTAI)
NASDAQ: BTAI
· Real-Time Price · USD
5.47
0.72 (15.16%)
At close: Aug 15, 2025, 3:59 PM
6.07
10.98%
After-hours: Aug 15, 2025, 07:58 PM EDT
BioXcel Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 868K | 1.85M | 2.27M | 2.28M | 2.4M | 1.76M | 1.38M | 1.24M | 1.04M | 581K | 375K | 137K | n/a | n/a | n/a | 0.02 | 0.03 | 0.03 |
Cost of Revenue | 2.2M | 2.08M | 2.22M | 2.18M | 1.52M | 1.49M | 1.34M | 556K | 55K | 113K | 181K | 248K | 313K | 309K | 297K | 221K | 145K | 14.86M |
Gross Profit | -1.32M | -212K | 44K | 94K | 879K | 268K | 41K | 686K | 983K | 468K | 194K | -111K | -313K | -309K | -297K | -221K | -145K | -14.86M |
Operating Income | -54.81M | -56.48M | -67.25M | -76.48M | -109.48M | -144.37M | -171.64M | -204.8M | -195.5M | -179.37M | -159.65M | -132.89M | -120.71M | -112.04M | -106.94M | -101.9M | -99.86M | -93.68M |
Interest Income | 2.27M | 2.71M | 2.6M | 3.18M | 3.63M | 4.58M | 5.65M | 6.19M | 5.95M | 4.53M | 2.53M | 1.05M | 243K | 49K | 44K | 32K | 40K | 58K |
Pretax Income | -50.95M | -40.06M | -59.6M | -71M | -107.83M | -153.05M | -179.05M | -211.6M | -202.92M | -187.08M | -165.75M | -137.07M | -122.08M | -112.03M | -106.93M | -101.89M | -99.83M | -93.63M |
Net Income | -50.95M | -40.06M | -59.6M | -71M | -107.83M | -153.05M | -177.28M | -213.11M | -207.25M | -192.78M | -173.22M | -141.26M | -123.45M | -112.02M | -106.93M | -101.89M | -99.83M | -93.63M |
Selling & General & Admin | 21.21M | 25.05M | 34.44M | 39.93M | 56.59M | 73.01M | 83.39M | 94.47M | 87.19M | 79.69M | 69.02M | 61.96M | 59.79M | 55.51M | 54.23M | 50.32M | 43.89M | 33.31M |
Research & Development | 25.81M | 23.59M | 30.17M | 34.2M | 48.72M | 67.66M | 84.33M | 106.85M | 109.29M | 100.23M | 90.99M | 71.05M | 60.92M | 56.53M | 52.71M | 51.58M | 55.97M | 60.37M |
Other Expenses | 6.65M | 7.4M | 2.44M | 2.43M | 5.04M | 4.18M | 3.94M | 3.44M | -664K | -664K | -418K | 62K | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 53.67M | 56.04M | 67.06M | 76.56M | 110.35M | 144.86M | 171.9M | 205.49M | 196.48M | 179.92M | 160.01M | 133.01M | 120.71M | 112.04M | 106.94M | 101.9M | 99.86M | 93.68M |
Interest Expense | 16.04M | 15.52M | 15.13M | 14.53M | 13.99M | 13.55M | 13.31M | 12.8M | 13.25M | 11.57M | 8.21M | 5.3M | 1.61M | 40K | 40K | 38K | 32K | 28K |
Selling & Marketing Expenses | 761K | 1.07M | 1.02M | 855K | 3.56M | 8.07M | 10.71M | 12.36M | 12.11M | 13.61M | 11.01M | 10.43M | 7.69M | 4.33M | 6.33M | 4.95M | 4.95M | 2M |
Cost & Expenses | 55.67M | 58.1M | 69.28M | 78.52M | 107.49M | 141.96M | 168.85M | 201.88M | 196.53M | 179.95M | 160.03M | 133.03M | 120.71M | 112.04M | 106.94M | 101.9M | 99.86M | 93.68M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -1.77M | 1.51M | 4.32M | 5.71M | 7.47M | 4.19M | 1.39M | 14K | 32K | -9K | -16K | -42K |
Shares Outstanding (Basic) | 7.84M | 2.54M | 2.54M | 16.7M | 16.7M | 30.87M | 29.45M | 29.27M | 29.19M | 28.62M | 28.07M | 28.02M | 27.99M | 27.98M | 27.98M | 27.97M | 24.96M | 24.52M |
Shares Outstanding (Diluted) | 7.84M | 2.54M | 2.54M | 16.7M | 16.7M | 30.87M | 29.45M | 29.27M | 29.19M | 28.62M | 28.07M | 28.02M | 27.99M | 27.98M | 27.98M | 27.97M | 24.96M | 24.52M |
EPS (Basic) | -10.41 | -8.46 | -6.47 | -2.95 | -3.85 | -5.18 | -6.09 | -7.4 | -7.27 | -6.84 | -6.18 | -5.04 | -4.41 | -4.12 | -4.08 | -4.02 | -4.13 | -4.08 |
EPS (Diluted) | -10.41 | -8.46 | -6.47 | -2.95 | -3.85 | -5.18 | -6.09 | -7.4 | -7.27 | -6.84 | -6.18 | -5.04 | -4.41 | -4.12 | -4.08 | -4.02 | -4.13 | -4.08 |
EBITDA | -39.24M | -27.91M | -44.16M | -56.15M | -93.53M | -139.11M | -165.35M | -198.41M | -189.69M | -175.59M | -157.65M | -131.89M | -120.21M | -111.75M | -106.66M | -101.65M | -99.59M | -93.42M |
EBIT | -38.91M | -28.54M | -44.47M | -56.46M | -93.84M | -139.5M | -165.74M | -197.71M | -189M | -174.96M | -156.99M | -132.32M | -120.61M | -112M | -106.9M | -101.87M | -99.8M | -93.61M |
Depreciation & Amortization | 628K | 630K | 309K | 310K | 312K | 388K | 390K | 393K | 399K | 330K | 327K | 322K | 313K | 309K | 297K | 266K | 238K | 206K |